| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMRX | Amneal Pharmaceuticals, Inc. | BUCHEN DAVID A | SVP, Chief Legal Officer | Jan 03, 2020 | Option Exercise | $4.72 | 8,188 | 38,647 | 20,426 | Jan 06, 2020, 05:20 PM | |
| ACT | Actavis plc | BUCHEN DAVID A | See Remarks | Mar 05, 2015 | Option Exercise | $295.70 | 717 | 212,017 | 74,050 | Mar 09, 2015, 06:09 PM | |
| ACT | Actavis plc | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | May 09, 2014 | Option Exercise | $197.05 | 2,960 | 583,268 | 62,926 | May 13, 2014, 05:22 PM | |
| ACT | Actavis plc | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | Nov 11, 2013 | Sale | $159.30 | 30,000 | 4,779,000 | 59,966 | Nov 13, 2013, 06:36 PM | |
| ACT | Actavis, Inc. | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | Sep 30, 2013 | Option Exercise | $144.00 | 45,848 | 6,602,112 | 89,966 | Oct 02, 2013, 08:49 PM | |
| ACT | Actavis, Inc. | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | Aug 29, 2013 | Option Exercise | $30.38 | 10,000 | 303,750 | 107,373 | Sep 03, 2013, 06:07 PM | |
| ACT | Actavis, Inc. | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | Aug 29, 2013 | Sale | $135.56 | 10,000 | 1,355,580 | 97,373 | Sep 03, 2013, 06:07 PM | |
| ACT | Actavis, Inc. | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | Aug 09, 2013 | Option Exercise | $26.14 | 200 | 5,228 | 97,573 | Aug 13, 2013, 05:15 PM | |
| ACT | Actavis, Inc. | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | Aug 09, 2013 | Sale | $135.00 | 200 | 27,000 | 114,173 | Aug 13, 2013, 05:15 PM | |
| ACT | Actavis, Inc. | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | Aug 12, 2013 | Option Exercise | $26.14 | 16,800 | 439,152 | 114,373 | Aug 13, 2013, 05:15 PM | |
| ACT | Actavis, Inc. | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | Aug 12, 2013 | Sale | $133.01 | 16,800 | 2,234,534 | 97,373 | Aug 13, 2013, 05:15 PM | |
| ACT | Actavis, Inc. | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | Mar 15, 2013 | Option Exercise | $91.59 | 933 | 85,453 | 97,373 | Mar 18, 2013, 04:27 PM | |
| ACT | Actavis, Inc. | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | Mar 12, 2013 | Option Exercise | $38.92 | 8,000 | 311,360 | 106,306 | Mar 13, 2013, 05:07 PM | |
| ACT | Actavis, Inc. | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | Mar 12, 2013 | Sale | $89.00 | 8,000 | 712,000 | 98,306 | Mar 13, 2013, 05:07 PM | |
| ACT | Actavis, Inc. | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | Mar 05, 2013 | Option Exercise | $86.46 | 3,896 | 336,848 | 83,630 | Mar 07, 2013, 02:54 PM | |
| ACT | Actavis, Inc. | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | Mar 02, 2013 | Option Exercise | $85.54 | 5,030 | 430,266 | 87,526 | Mar 05, 2013, 07:17 PM | |
| WPI | WATSON PHARMACEUTICALS INC | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | Aug 24, 2012 | Sale | $81.56 | 24,294 | 1,981,419 | 86,739 | Aug 24, 2012, 06:39 PM | |
| WPI | WATSON PHARMACEUTICALS INC | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | Aug 24, 2012 | Option Exercise | $29.43 | 25,000 | 735,750 | 111,033 | Aug 24, 2012, 06:39 PM | |
| WPI | WATSON PHARMACEUTICALS INC | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | May 25, 2012 | Option Exercise | $72.67 | 6,366 | 462,617 | 86,033 | May 30, 2012, 02:08 PM | |
| WPI | WATSON PHARMACEUTICALS INC | BUCHEN DAVID A | Chief Legal Officer-Global&Sec | May 25, 2012 | Option Exercise | $26.40 | 15,000 | 396,000 | 92,399 | May 30, 2012, 02:08 PM | |
| WPI | WATSON PHARMACEUTICALS INC | BUCHEN DAVID A | Exec VP,General Counsel & Sec. | Mar 14, 2012 | Option Exercise | $59.21 | 2,473 | 146,426 | 77,399 | Mar 16, 2012, 02:16 PM | |
| WPI | WATSON PHARMACEUTICALS INC | BUCHEN DAVID A | Exec VP,General Counsel & Sec. | Feb 24, 2012 | Option Exercise | $58.17 | 2,754 | 160,200 | 63,818 | Feb 28, 2012, 12:19 PM | |
| WPI | WATSON PHARMACEUTICALS INC | BUCHEN DAVID A | Exec VP,General Counsel & Sec. | Aug 26, 2011 | Option Exercise | $28.15 | 17,500 | 492,625 | 84,072 | Aug 29, 2011, 04:14 PM | |
| WPI | WATSON PHARMACEUTICALS INC | BUCHEN DAVID A | Exec VP,General Counsel & Sec. | Aug 26, 2011 | Sale | $65.50 | 17,500 | 1,146,250 | 66,572 | Aug 29, 2011, 04:14 PM | |
| WPI | WATSON PHARMACEUTICALS INC | BUCHEN DAVID A | Exec VP,General Counsel & Sec. | May 27, 2011 | Option Exercise | $54.48 | 7,000 | 381,360 | 73,572 | May 31, 2011, 04:36 PM | |
| WPI | WATSON PHARMACEUTICALS INC | BUCHEN DAVID A | Exec VP,General Counsel & Sec. | May 27, 2011 | Sale | $64.10 | 7,000 | 448,700 | 66,572 | May 31, 2011, 04:36 PM | |
| WPI | WATSON PHARMACEUTICALS INC | BUCHEN DAVID A | Exec VP,General Counsel & Sec. | Mar 11, 2011 | Option Exercise | $56.89 | 1,375 | 78,224 | 62,978 | Mar 15, 2011, 04:09 PM | |
| WPI | WATSON PHARMACEUTICALS INC | BUCHEN DAVID A | Sr. VP, General Counsel & Sec. | Mar 05, 2011 | Option Exercise | $56.79 | 2,747 | 156,002 | 64,353 | Mar 08, 2011, 04:27 PM | |
| WPI | WATSON PHARMACEUTICALS INC | BUCHEN DAVID A | Sr. VP, General Counsel & Sec. | Mar 03, 2011 | Sale | $57.11 | 5,000 | 285,550 | 67,100 | Mar 04, 2011, 04:28 PM | |
| WPI | WATSON PHARMACEUTICALS INC | BUCHEN DAVID A | Sr. VP, General Counsel & Sec. | Mar 03, 2011 | Option Exercise | $48.90 | 5,000 | 244,500 | 72,100 | Mar 04, 2011, 04:28 PM | |
| WPI | WATSON PHARMACEUTICALS INC | BUCHEN DAVID A | Sr. VP, General Counsel & Sec. | Sep 01, 2010 | Option Exercise | $44.15 | 305 | 13,466 | 52,066 | Sep 02, 2010, 06:20 PM |
Menu